Relapsed Small Lymphocytic Lymphoma Recruiting Phase 2 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0023539 (Relapsed Small Lymphocytic Lymphoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04191187Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic MalignanciesTreatment
NCT02722668UCB Transplant for Hematological Diseases Using a Non Myeloablative PrepTreatment